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Objectives: This study extended and updated a meta-analysis of the association
between exposure to dichlorodiphenyltrichloroethane (DDT) and the risk of
breast cancer.
Methods: We reviewed the published literature on exposure to DDE and breast
cancer risk to update a meta-analysis from 2004. The total of 35 studies included
16 hospital-based caseecontrol studies, 11 population-based caseecontrol
studies, and 10 nested caseecontrol studies identified through keyword searches
in the PubMed and EMBASE databases.
Results: The summary odds ratio (OR) for the identified studies was 1.03 (95% con-
fidence interval 0.95e1.12) and the overall heterogeneity in the OR was observed
(I2Z 40.9; pZ 0.006). Subgroup meta-analyses indicated no significant association
between exposure to DDE and breast cancer risk by the type of design, study years,
biological specimen, and geographical region of the study, except from population-
based caseecontrol studies with estimated DDE levels in serum published in 1990s.
Conclusion: Existing studies do not support the view that DDE increases the risk of
breast cancer in humans. However, further studies incorporating more detailed
information on DDT exposure and other potential risk factors for breast cancer are
needed.1. Introduction
Dichlorodiphenyltrichloroethane (DDT) is a synthetic
chemical that includes p,p0-dichlorodiphenyltrichloro-
ethane (p,p0-DDT), p,p0-dichlorodiphenyldichloroethyleneted under the terms of the C
0) which permits unrestrict
roperly cited.
ase Control and Prevention(p,p0-DDE), and p,p0-dichlorodiphenyldichloroethane
(p,p0-DDD or p,p0-TDE). DDE (dichlorodiphenyldi-
chloroethylene) is the main metabolite of DDT, which is
rapidly converted intoDDE in biological systems [1]. After
identifying its insecticidal function, DDT was widely usedreative Commons Attribution Non-Commercial License (http://
ed non-commercial use, distribution, and reproduction in any
. Published by Elsevier Korea LLC. All rights reserved.
78 J.-H. Park, et alto prevent malaria and some agricultural pests worldwide.
Although the use of DDT was banned in most developed
countries in the early 1970s, DDT was still used in some
developingcountries, suchas India, Indonesia, andMexico,
until the 1990s to control themosquitoes that causemalaria
[1,2].
DDT is bioaccumulated in the lipid component of
biological systems through the food chain because it is
highly lipophilic and is resistant to degradation. There-
fore, despite its prohibition in many countries, DDT is
still present in the environment and the food chain. DDE
in particular has a very long half-life and is of toxico-
logical importance. The half-lives of DDT and DDE in
humans have been estimated to be between 6 years and 10
years [3]. The DDT and DDE accumulated in the lipid
components, such as adipose tissue, are slowly released
into the bloodstream [4]. DDT and its metabolites have
been associated with adverse effects including obesity,
type 2 diabetes mellitus, and carcinogenicity [5e7].
These chemicals can affect various tissues through
mechanisms involving the steroidogenic pathway such as
antiandrogenic or estrogenic activity, and receptor-
mediated changes in protein synthesis [8e10].
Since DDT and DDE were first reported to be related
to breast cancer in 1993 [11], there has been increased
attention on the association between exposure to DDT
and the risk of breast cancer. Although many epidemi-
ological studies have been conducted to investigate the
relationship between DDT exposure and breast cancer
risk, there is a large heterogeneity between studies and
the findings are not conclusive. Because a meta-analysis
study showed no evidence of an association between
DDT exposure and breast cancer risk [12], several new
epidemiological studies have been published about the
relationship between the body burden of DDT and breast
cancer risk [13e18].Database search
PubMed (n=337), EMBASE (n=193)
Articles remaining after excluding
(n=137)
Articles remaining after excluding 
duplicated articles (n=103)
Remaining articles (n=44), full text review
35 articles included in the final meta-analysis
Figure 1. Process usedIn the work reported here, we aimed to provide an
update of a systematic review and meta-analysis to es-
timate the association between DDE exposure and the
risk of breast cancer based on study characteristics.2. Materials and methods
2.1. Study selection
We searched and reviewed the PubMed and
EMBASE databases to identify eligible epidemiological
studies published in English up to August 2012 using
selected common keywords related to DDT exposure
and the risk of breast cancer. The reference lists of the
identified papers and previous literature reviews were
carefully examined for additional studies. The combi-
nation of keywords such as DDT, chlorphenotane,
dichlorodiphenyldichloroethylene, DDE, p,p0-DDE, 1,1-
dichloro-2,2-bis(4 chlorophenyl)ethylene, hydrocarbons,
chlorinated, organochlorines, organochlorine pesticides,
breast cancer, and breast neoplasm were entered as both
medical subject heading (MeSH) terms and text words.
The subject of the papers was limited to humans for all
databases. We included epidemiological studies that met
the following criteria: (1) studies that presented original
data from caseecontrol or cohort studies; (2) the
outcome of interest was clearly defined as breast cancer;
(3) the exposure of interest was DDT or DDT metabo-
lites; and (4) studies that provided measurements with
relative risk estimates and 95% confidence intervals
(CIs), odds ratios (ORs) and 95% CIs, or values in cells
of a 2  2 table (e.g., number of cases and controls in
exposure categories from which the OR could be
calculated). If the data were duplicated or shared in more
than one study, only the most recent or more compre-
hensive study was included in the analysis.Exclude according to title (n=393)
Exclude duplicated articles (n=34)
Exclude according to selection
criteria after abstract review (n=59)
Exclude according to selection
criteria after full text review (n=9)
for literature search.
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All studies for which an abstract was present were
reviewed and extracted independently by two evaluators
(E.S.C. and Y.K.) according to the Meta-analysis of
Observational Studies in Epidemiology (MOOSE)
guidelines [19]. Disagreements between evaluators about
selected studies were resolved by discussion. The
following data were extracted from the eligible studies
and included in the final analysis: first author’s name,
publication year, study years, country, study design,
number of participants (cases and controls), type of bio-
logical specimen, and OR with 95% CIs for association
between the exposure of DDT and breast cancer.Table 1. Summary of papers included in the meta-analysis for
Author (year) Study years Country
Aronson (2000) [26] 1995e1997 Canada Ho
Charlier (2004) [14] 2001e2002 Belgium Po
Cohn (2007) [27] 1959e1967 USA Ho
Dello Lacovo (1999) [28] 1997e1998 Italy Po
Demers (2000) [29] 1994e1997 Canada Po
Demers (2000) [29] 1994e1997 Canada Ho
Dorgan (1999) [30] 1977e1987 USA Ne
Gammon (2002) [15] 1996e1997 USA Po
Gatto (2007) [31] 1995e1998 USA Po
Helzlsouer (1999) [32] 1974 USA Ne
Helzlsouer (1999) [32] 1989 USA Ne
Hoyer (1998) [33] 1976 Denmark Ne
Hoyer (2000) [34] 1976e1978/
1981e1983
Denmark Ne
Ibarluzea (2004) [16] 1996e1998 Spain Ho
Itoh (2009) [35] 2001e2005 Japan Po
Iwasaki (2008) [17] 1990e1995 Japan Ne
Krieger (1994) [36] 1964e1969 USA Ne
Laden (2001) [37] 1989e1990 USA Ne
Liljegren (1998) [38] 1993e1995 Sweden Ho
Lopez-Carrillo (1997) [39] 1994e1996 Mexico Ho
McCready (2004) [18] 1995e1997 Canada Ho
Mendonca (1999) [40] 1995e1996 Brazil Ho
Millikan (2000) [41] 1993e1996 USA Po
Moysich (1998) [42] 1986e1991 USA Po
Olaya-Contreras
(1998) [21]
1995e1996 Colombia Ho
Pavuk (2003) [43] 1997e1999 USA Ho
Raaschou-Nielsen
(2005) [44]
1993e1997 Denmark Ne
Romieu (2000) [22] 1990e1995 Mexico Po
Rubin (2005) [45] 1981e1987 USA Po
Schecter (1997) [46] 1994 Vietnam Ho
Stellman (2000) [47] 1994e1996 USA Ho
van’t Veer (1997) [48] 1991e1992 Five European
countries
Ho
Wolff (1993) [11] 1985e1991 USA Po
Wolff (2000) [49] 1994e1996 USA Ho
Wolff (2000) [50] 1987e1992 USA Ne
Zheng (1999) [51] 1994e1997 USA Ho
Zheng (2000) [52] 1995e1997 USA Ho
CC Z case-control study; CI Z confidence interval; OR Z odds ratio.2.3. Statistical analysis
Meta-analytic techniques that weight the logarithm
of the OR of each study by a function of its variance
were used to calculate a summary estimate. Meta-
analyses were performed on the total data set and
separately for the type of design (hospital-based
caseecontrol, population-based caseecontrol, and
nested caseecontrol), study years (2000s, 1990s,
1980s, 1970s, and 1960s), biological specimen (serum,
plasma, and adipose tissue), and geographical region of
the study (North America, Europe, Asia, and South
America). A random effect model was used to estimate
pooled ORs regarding the potential heterogeneity ofDDT exposure and breast cancer risk
Design
n (cases/
controls)
Biological
specimen OR (95% CI)
spital CC 217/213 Adipose tissue 1.10 (0.78e1.55)
pulation CC 231/290 Serum 2.21 (1.41e3.48)
spital CC 129/129 Serum 1.29 (0.85e1.96)
pulation CC 170/195 Serum 1.02 (0.68e1.54)
pulation CC 315/307 Plasma 0.91 (0.70e1.17)
spital CC 315/219 Plasma 1.01 (0.74e1.39)
sted CC 105/207 Serum 0.70 (0.47e0.99)
pulation CC 643/427 Serum 1.20 (0.76e1.90)
pulation CC 355/327 Serum 1.05 (0.82e1.35)
sted CC 235/235 Serum 0.94 (0.71e1.25)
sted CC 105/105 Serum 0.88 (0.56e1.38)
sted CC 237/469 Serum 0.88 (0.56e1.37)
sted CC 240/477 Serum 1.04 (0.70e1.55)
spital CC 198/260 Adipose tissue 1.16 (0.83e1.62)
pulation CC 349/349 Serum 0.74 (0.48e1.13)
sted CC 139/278 Plasma 1.23 (0.80e1.90)
sted CC 150/150 Serum 1.31 (0.82e2.09)
sted CC 372/372 Plasma 0.79 (0.61e1.01)
spital CC 43/35 Adipose tissue 0.40 (0.10e1.20)
spital CC 141/141 Serum 0.68 (0.43e1.07)
spital CC 68/52 Adipose tissue 2.48 (1.08e5.71)
spital CC 162/331 Serum 1.05 (0.75e1.46)
pulation CC 748/659 Plasma 1.07 (0.86e1.32)
pulation CC 154/192 Serum 1.15 (0.74e1.79)
spital CC 153/153 Serum 1.56 (1.02e2.39)
spital CC 24/85 Serum 1.49 (0.45e4.87)
sted CC 363/363 Adipose tissue 0.87 (0.69e1.10)
pulation CC 120/126 Serum 2.02 (1.14e3.57)
pulation CC 63/63 Serum 0.97 (0.41e2.32)
spital CC 21/21 Serum 0.69 (0.23e2.07)
spital CC 232/323 Adipose tissue 0.94 (0.66e1.33)
spital CC 265/341 Adipose tissue 0.75 (0.52e1.08)
pulation CC 58/171 Serum 2.30 (1.31e4.04)
spital CC 151/317 Serum 0.86 (0.61e1.22)
sted CC 110/213 Serum 0.83 (0.50e1.37)
spital CC 304/304 Adipose tissue 1.02 (0.73e1.41)
spital CC 475/502 Serum 1.01 (0.79e1.28)
NOTE: Weights are from random effects analysis
Overall  (I-squared = 40.9%, p = 0.006)
Mendonca (1999)
Laden (2001)
Charlier (2004)
Gatto (2007)
Romieu (2000)
Wolff (2000b)
Zheng (1999)
Schecter (1997)
Wolff (1993)
Dorgan (1999)
Wolff (2000a)
Author
Demers (2000b)
Stellman (2000)
Olaya-Contreras (1998)
Iwasaki (2008)
Liljegren (1998)
Krieger (1994)
Millikan (2000)
Hoyer (2000)
Pavuk (2003)
Helzlsouer (1999b)
Moysich (1998)
van't Veer (1997)
Itoh (2009)
Ibarluzea (2004)
Raaschou-Nielsen (2005)
Hoyer (1998)
Helzlsouer (1999a)
Zheng (2000)
Cohn (2007)
Rubin (2005)
Gammon (2002)
Dello lacovo (1999)
McCready (2004)
Lopez-Carrillo (1997)
Demers (2000a)
Aronson (2000)
Weight (%)
1.03 (0.95, 1.12)
1.05 (0.75, 1.47)
0.79 (0.61, 1.02)
2.20 (1.41, 3.45)
1.05 (0.82, 1.34)
2.02 (1.14, 3.58)
0.86 (0.61, 1.21)
1.02 (0.73, 1.43)
0.69 (0.23, 2.07)
2.30 (1.31, 4.04)
0.70 (0.47, 1.04)
0.83 (0.50, 1.38)
(95% CI)
0.91 (0.70, 1.18)
0.94 (0.66, 1.34)
1.56 (1.02, 2.39)
1.23 (0.80, 1.89)
0.40 (0.10, 1.60)
1.31 (0.82, 2.09)
1.07 (0.86, 1.33)
1.04 (0.70, 1.55)
1.49 (0.45, 4.93)
0.88 (0.56, 1.38)
1.15 (0.74, 1.79)
0.75 (0.52, 1.08)
0.74 (0.48, 1.14)
1.16 (0.83, 1.62)
0.87 (0.69, 1.10)
0.88 (0.56, 1.38)
0.94 (0.71, 1.24)
1.01 (0.79, 1.29)
1.29 (0.85, 1.96)
0.97 (0.41, 2.29)
1.20 (0.76, 1.89)
1.02 (0.68, 1.53)
2.48 (1.08, 5.69)
0.68 (0.43, 1.08)
1.01 (0.74, 1.38)
1.10 (0.78, 1.55)
Odds ratio
100.00
3.33
4.29
2.34
4.45
1.64
3.26
3.35
0.53
1.68
2.74
1.97
4.24
3.15
2.52
2.48
0.34
2.21
4.87
2.76
0.45
2.32
2.40
3.03
2.46
3.35
4.67
2.32
4.00
4.47
2.58
0.83
2.29
2.67
0.88
2.27
3.62
3.26
0.1 0.5 1 2 10
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R
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Egger’s test: p for bias = 0.145
standard error of log OR
Figure 2. (A) Odds ratios (ORs) for DDT exposure and breast cancer. (B) Funnel plot of all included studies.
80 J.-H. Park, et althe study populations. Statistical heterogeneity be-
tween studies was assessed with the Q-statistics and
quantified by I2, which measured the percentage of
total variation in included studies [20]. Significant
heterogeneity was defined as the Q-statistics test p <0.1 or I2 greater than 50%. We assessed potential
publication bias by examining funnel plots and using
Egger’s test. All the statistical analyses were per-
formed using the Stata 12.0 software (StataCorp,
College Station, TX, USA).
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The PubMed and EMBASE search yielded 530 pa-
pers and 44 papers remained after screening based on
the inclusion criteria. On reviewing of the full text of the
remaining 44 papers, we identified 35 papers on the
exposure to DDE and the risk of breast cancer. Two
papers each consisted of two subpopulations and we
treated the data of each subgroup as a separate study
(Figure 1).
Table 1 gives the details of the 35 studies that were
included in the meta-analysis. All were caseecontrol
studies and of these 10 were prospective (nested
caseecontrol) and 16 were hospital based caseecontrol
studies, and 11 were population based caseecontrol
studies, which consist of 8160 cases and 9280 controls.
Five studies indicated a significant positive association
with the risk of breast cancer, whereas no significant
association was observed in 32 studies. Twenty-two
studies conducted in the USA and Canada, eight in
Europe, three in Asia, and four in South America. In
most studies, the level of DDE was measured in serum
samples.
Overall, there was no significant association between
the exposure to DDE and the risk of breast cancer in the
meta-analysis of all caseecontrol studies (OR 1.03, 95%
CI 0.95e1.12; Figure 2A) and there was some evidence
for heterogeneity (p Z 0.006, I2 Z 40.9). However, no
significant publication bias was observed in the selected
studies (Begg’s funnel plot was symmetric; Egger’s test,
p for bias Z 0.145; Figure 2B).Table 2. Meta-analysis of the effect of the exposure to DDT o
Studies included
No. of
Studies OR 95%
Type of study design
Hospital CC 16 1.02 0.91 to
Population CC 11 1.19 0.99 to
Nested CC 10 0.90 0.81 to
Study years
2000s 2 1.28 0.44 to
1990s 27 1.03 0.94 to
1980s 4 0.87 0.69 to
1970s 2 0.92 0.73 to
1960s 2 1.30 0.95 to
Type of biologic specimen
Serum 24 1.07 0.93 to
Plasma 5 0.97 0.85 to
Adipose tissue 8 0.98 0.83 to
Country
North America 22 1.01 0.92 to
Europe 8 1.02 0.81 to
Asia 3 0.92 0.63 to
South America 4 1.20 0.78 to
CC Z caseecontrol study; CI Z confidence interval; OR Z odds ratio.To resolve the heterogeneity, we performed subgroup
meta-analyses by the type of study design, study years,
type of biological specimen, and country (Table 2). We
found a borderline statistically significant summary OR
for population-based caseecontrol studies with 1.19
(95% CI 0.99e1.44), although there was a considerable
heterogeneity based on the 11 studies (I2 Z 61.3).
However, there was no significant association in other
subgroup meta-analysis.
Figure 3 shows the subgroup meta-analysis for
population-based case-control studies with estimated
DDE levels in serum published in 1990s. The OR for
this subgroup indicated 1.28 (95% CI 1.00e1.65;
Figure 3A), although there was a high heterogeneity
(Figure 3B). In other stratified meta-analyses, there was
no significant association between exposure to DDE and
the risk of breast cancer (data not shown).4. Discussion
We found that there was no significant evidence of an
association between the risk of breast cancer and expo-
sure to DDE with recent published literature. Subgroup
meta-analyses by the type of design, study years, bio-
logical specimen, and geographical region of study also
do not support a relationship between exposure to DDE
and the risk of breast cancer. However, population-based
caseecontrol studies with estimated DDE levels in serum
and published in the 1990s showed marginally significant
findings, which need further investigation.n the risk of breast cancer according to subgroup
CI
Heterogeneity
Egger’s test
(p for bias)p-value I2 (%)
1.15 0.183 24.0 0.780
1.44 0.004 61.3 0.212
1.01 0.554 0.0 0.274
3.71 0.001 91.5 e
1.24 0.034 35.9 0.169
1.09 0.575 0.0 0.908
1.17 0.808 0.0 e
1.77 0.962 0.0 e
1.11 0.006 47.0 0.365
1.11 0.325 14.1 0.910
1.16 0.141 36.0 0.228
1.10 0.185 21.0 0.524
1.29 0.010 62.0 0.246
1.36 0.226 32.8 0.900
1.83 0.012 72.8 0.707
NOTE: Weights are from random effects analysis
Overall  (I-squared = 63.8%, p = 0.005)
Wolff (1993)
Romieu (2000)
Moysich (1998)
Charlier (2004)
Itoh (2009)
Author
Dello lacovo (1999)
Gatto (2007)
Gammon (2002)
Rubin (2005)
1.28 (1.00, 1.65)
2.30 (1.31, 4.04)
2.02 (1.14, 3.58)
1.15 (0.74, 1.79)
2.20 (1.41, 3.45)
0.74 (0.48, 1.14)
1.02 (0.68, 1.53)
1.05 (0.82, 1.34)
1.20 (0.76, 1.89)
0.97 (0.41, 2.29)
100.00
9.60
9.45
11.80
11.64
11.96
12.50
15.74
11.50
5.82
0.248 1 4.04
Weight (%)(95% CI)
Odds ratioA
B Begg's funnel plot with pseudo 95% confidence limits
lo
g 
O
R
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standard error of log OR
Figure 3. (A) Odds ratios for DDT exposure and breast cancer in population-based caseecontrol studies. (B) Funnel plot of
population-based caseecontrol studies.
82 J.-H. Park, et alMany studies did not report an increased risk, despite
the first publication reporting an excess of breast cancer
associated with exposure to DDE [11]. Five studies
[11,14,18,21,22] among the 35 pooled studies included
in our meta-analysis found a positive association be-
tween exposure to DDE and the risk of breast cancer.
There was moderate heterogeneity among the pooled
studies. The inconsistency and heterogeneity of the
studies could be explained by potential confounders or
modifiers that might affect the relationship between
DDE and the risk of breast cancer. One potential
explanation for the huge differences in the risk of breast
cancer and the moderate heterogeneity among pooled
studies is that there is a delayed time between exposure
and diagnosis. As DDT can remain in the body for a
long period, there is a limitation to identifying accu-
rately the exposure period and levels of exposure.As DDT crosses the placenta to the fetus and is
secreted in breast milk [23], human exposure begins
during the early prenatal period and continues during the
breastfeeding neonatal period. Evidence for DDE
release from fat storage tissue in humans has been
provided by breastfeeding studies, which have been
found to decrease the risk of breast cancer [24,25].
Exposure during the prenatal and neonatal periods may
reduce the distinction between the exposed and unex-
posed groups and make it harder for such studies to
show a true causal association. The age at exposure to
chemicals such as DDE is also an important modifier in
explaining the relationship between exposure and the
risk of disease. Cohn et al [27] reported that DDT was
associated with breast cancer only for women poten-
tially exposed at a young age (prior to 14 years of age).
Thus the relationship between age at exposure to DDT
Exposure to DDT metabolites and breast cancer risk 83and breast cancer represents an important area in need of
further research.
The other limitation is combined exposure with other
chemicals in the natural environment. Many persistent
organic pollutants, includingDDT, are known or suspected
tobeendocrinedisruptors.However, thesechemicals donot
all have the same effect; some chemicals have an agonistic
role in estrogenic effects, but others have an antagonistic
role. Thus current estimations may rule out the possibility
that there is a particular hazard from these mixtures or one
chemical, whereas exposure to several different chemicals
may have a pronounced effect due to their combination.
In summary, our meta-analysis found no evidence
that there is an association between exposure to DDE
and the risk of breast cancer. Although our results
indicate no relationship, there are still several limitations
to this study, such as the delay time between exposure
and diagnosis, age of exposure, the effect of susceptible
populations, and combined exposure with other potential
carcinogens. It is particularly important to recommend
studying the relationship between DDT and breast can-
cer based on age of exposure and combined exposure to
a number of potential carcinogens.Conflicts of interest
All contributing authors declare no conflicts of
interest.Acknowledgments
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